BRCA1 and neoplasm: While the full-length BARD1 protein participates in both BRCA1-dependent and BRCA1-independent tumor-suppressive pathways, multiple exon-skipping BARD1 isoforms, many of which have agonistic cancer susceptibility potential, have been reported15.